DGQuest Diagnostics DGX · NYSE
$241.81 -0.60% (-$1.47)
- Market cap
- $25.9B
- Enterprise value
- $31.7B
- P/E
- 24.4x
- Forward P/E
- 20.5x
- PEG
- 1.9x
- P/S
- 2.2x
- P/FCF
- 21.3x
- EV/EBITDA
- 15.8x
- ROIC
- 8.3%
- Gross margin
- 33.1%
- Net margin
- 9.2%
- Dividend yield
- 1.44%
- Payout ratio
- 35.1%
- Net debt/EBITDA
- 2.9x
- Beta
- 0.54
- Free float
- 99.5%
About the company
Quest Diagnostics Incorporated (DGX) is an American company that provides diagnostic information and services for healthcare. The company offers a wide range of laboratory tests and diagnostic services, including blood tests, genetic tests, tests for infectious diseases, and screening tests for disease prevention. With an extensive network of laboratories and partnerships with healthcare providers, Quest Diagnostics is one of the leading providers of diagnostic services in the United States. The company is known for its quality, reliability, and ability to provide comprehensive diagnostic information for physicians and patients. Quest Diagnostics Incorporated (DGX) shares could be suitable for investors looking to invest in companies providing healthcare services and diagnostic information with a strong market position and a good reputation in the healthcare industry.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
Employees
51,500
Headquarters
Secaucus
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number